Daehan New Pharm Co Ltd
KOSDAQ:054670
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Daehan New Pharm Co Ltd
KOSDAQ:054670
|
KR |
|
E
|
Exprivia SpA
MIL:XPR
|
IT |
|
T
|
Tamai Steamship Co Ltd
TSE:9127
|
JP |
|
biOasis Technologies Inc
XTSX:BTI
|
CA |
|
F
|
Flair Writing Industries Ltd
NSE:FLAIR
|
IN |
|
Asia Financial Holdings Ltd
HKEX:662
|
HK |
|
Jamna Auto Industries Ltd
NSE:JAMNAAUTO
|
IN |
|
Ashland Inc
F:AHT
|
US |
|
Youngone Holdings Co Ltd
KRX:009970
|
KR |
|
A
|
AMA Marine PCL
SET:AMA
|
TH |
|
Columbia Banking System Inc
NASDAQ:COLB
|
US |
|
iSun Inc
OTC:ISUNQ
|
US |
|
Stealth Global Holdings Ltd
ASX:SGI
|
AU |
|
D
|
DYPNF Co Ltd
KOSDAQ:104460
|
KR |
|
S
|
Suzhou Delphi Laser Co Ltd
SSE:688170
|
CN |
|
Strike Resources Ltd
ASX:SRK
|
AU |
|
L
|
Lycos Energy Inc
XTSX:LCX
|
CA |
|
C
|
Coolpad Group Ltd
HKEX:2369
|
CN |
|
F
|
Fujian South Highway Machinery Co Ltd
SSE:603280
|
CN |
|
Mitsui E&S Holdings Co Ltd
TSE:7003
|
JP |
|
Sanyei Corp
TSE:8119
|
JP |
|
Nanjing Develop Advanced Manufacturing Co Ltd
SSE:688377
|
CN |
|
M
|
MMAG Holdings Bhd
KLSE:MMAG
|
MY |
|
Jinko Solar Co Ltd
SSE:688223
|
CN |
Multiples-Based Value
The Multiples-Based Value of one Daehan New Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 7 260 KRW, Daehan New Pharm Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Daehan New Pharm Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
D
|
Daehan New Pharm Co Ltd
KOSDAQ:054670
|
101.9B KRW | 0.5 | 9.4 | 9.2 | 12.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |